Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
Key facts
- Who runs it
- Nemours Children's Clinic
- Where
- Jacksonville and Wilmington, United StatesSee the 2 sites
- Trial code
- Status
- Terminated
- People taking part
- 3 people enrolled
- Started
- 11 Feb 2021
- Ended
- 28 Mar 2024
- Type of study
- Observational
- Treatments tested
- Quality of Life Assessment
- Transarterial Radioembolization
- Record updated
- 12 June 2024
- Why it stopped
- PI left organization and discontinued study
Who can take part
- Age
- 0 years to 21 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Boys and girls age < 21 years of age
- History of liver tumor
- Meet criteria for treatment with TARE-Y90
Who cannot take part
- • Inability to complete required study procedures
Where in United States
- Nemours Children's Specialty CareJacksonville, United States
- Nemours-AI duPont Hospital for ChildrenWilmington, United States
About the trial
What the trial wants to find out
This study will be performed to evaluate the Clinical Outcomes and Quality of Life after Transarterial Radioembolization with Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults with Liver Tumors. The treatment and techniques used here are well established in adults.
Read full original descriptionShow less
The purpose of this study is to evaluate:
1. the response to treatment and clinical outcomes of treatment with TARE Y-90 as part of standard therapy and 2. to assess the change in the patient's quality of life before, during and after treatment with TARE-Y90
The group in the trial
- Standard Treatment
Evaluation of change of HRQOL survey responses will be performed: * at baseline (time of treatment) and * 1 month post treatment * 6 months post treatment * 12 months post treatment * 5 years post-treatment The HRQOL will be done by phone, mail or email. Responses will be captured and entered into a REDCAP database
Treatment: Quality of Life Assessment and Transarterial Radioembolization
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Outcomes and Quality of Life After Transarterial Radioembolization With Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
- Record updated
- 12 June 2024